Caresyntax Grabs $30M Series C Extension
Summary
Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced a $30 million extension to its Series C funding round, initially led by PFM Health Sciences, LP. The additional investment brings the total Series C funding to $130 million, building on the first stage announced in April 2021. This real-world evidence can be used by the care team live, during a procedure and accessed by those outside the operating room via the platforms dedicated telehealth link. After a procedure, the Caresyntax platform provides insights that help: surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. Founded by entrepreneurs Dennis Kogan and Björn von Siemens, Caresyntax software is used in more than 4,000 operating rooms worldwide and supports surgical teams in over two million procedures per year.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
